COMMUNIQUÉS West-GlobeNewswire

argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
08/05/2026
VYVGART and VYVGART Hytrulo are the first and only approved treatments for all serotypes of adult patients living with gMG – anti-AChR-Ab positive, anti-MuSK-Ab positive, anti-LRP4-Ab positive, and triple seronegative [...]
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
08/05/2026
-- With fertility rates at historic lows, Femasys advances access to early infertility care through FemaSeed® Complete, enabling OB/GYNs to treat patients within their own practices -- ATLANTA, May 08, 2026 (GLOBE [...]
Shiny Smile Veneers Under Investigation: Evaluating the Dentist-Designed Custom Fit Snap-On Top & Bottom Veneer Claims
08/05/2026
How Shiny Smile Veneers' At-Home Snap-On Custom Fit System, Dr. Dean's Dentist-Designed Process, FDA-Approved Material Claims, 60-Day Guarantee Terms, and Consumer Complaints and Reviews Stack Up in 2026 Richardson, TX [...]
Her Bodhi Claims Evaluated: Meno & Hormonal Support for Women by HerBodhi Under Investigation
08/05/2026
Her Bodhi Meno Ingredient Research: KSM-66 Ashwagandha, Black Cohosh, and Red Clover Ingredients, Side Effects, Pricing, and Refund Policy for Menopause Support in 2026 Los Angeles, CA, May 08, 2026 (GLOBE NEWSWIRE) -- [...]
More Life Summit 2026 Brings the World's Leading Voices in Longevity, Performance, Faith & Purpose to Miami this October
08/05/2026
Two-Day Premium Experience at the James L. Knight Center Headlined by Human Biologist Gary Brecka and 2x Mr. Olympia Derek Lunsford, with Title Sponsor AllCore360° MIAMI, Fl., May 08, 2026 (GLOBE NEWSWIRE) -- [...]
Fitness Online Named “Best Fitness Mobile App” in 10th Annual MedTech Breakthrough Awards Program
08/05/2026
Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- MedTech Breakthrough , an independent market [...]
Major Shareholder Announcement
08/05/2026
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; May 8, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis [...]
Erdem Health Group Enters Türkiye’s TURQUALITY Program
08/05/2026
The recognition supports Istanbul-based healthcare group’s international brand strategy and reinforces its quality-focused growth in health tourism Erdem Health Group has been accepted into TURQUALITY®, Türkiye’s state- [...]
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million
08/05/2026
SOUTH SAN FRANCISCO, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the closing of an underwritten public offering of 11,338,028 shares of its common stock, including [...]
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
08/05/2026
Enrollment proceeding in KOMODO-1 first-in-human clinical trial of BBI-940 $93 million in cash provides runway through expected clinical proof-of-concept readout for KOMODO-1 SAN DIEGO, May 08, 2026 (GLOBE NEWSWIRE) -- [...]
Avicanna Announces Results of Annual General and Special Meeting
08/05/2026
TORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of [...]
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
08/05/2026
Topline results from healthy volunteer study and clinical development strategy for next-generation STAT3 inhibitor, TTI-109, anticipated in June Topline data from Phase 2 trial of TTI-101 in hepatocellular carcinoma ( [...]
Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update
08/05/2026
PMA submission targeted for May 29, 2026 in alignment with FDA Vantive commits to additional funding support ahead of PMA acceptance milestone TORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” [...]
MapLight Therapeutics to Participate in Upcoming Investor Conferences
08/05/2026
SAN FRANCISCO and BOSTON, May 08, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its management team will participate in the following investor conferences: Event : [...]
Global Ovarian Cancer Research Consortium Announces Next AI Accelerator Grant to Advance Data-Driven Discovery
08/05/2026
On World Ovarian Cancer Day, May 8, the Global Ovarian Cancer Research Consortium announces a second $1 million USD grant along with AWS compute support to power research to improve ovarian cancer survival rates TORONTO [...]
Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastases
08/05/2026
Plenary session at AANS underscores REYOBIQ’s potential as a differentiated targeted radiotherapeutic platform for CNS cancers HOUSTON, Texas, May 08, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“ [...]
Hyperion DeFi Announces Closing of Public Offering of Common Stock
08/05/2026
DALLAS, May 08, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it has closed its [...]
Le Consortium international de recherche sur le cancer de l’ovaire annonce une nouvelle bourse pour des recherches propulsées par l’IA, visant à faire progresser les découvertes fondées sur les données
08/05/2026
Le 8 mai, à l’occasion de la Journée mondiale du cancer de l’ovaire, le Consortium international de recherche sur le cancer de l’ovaire annonce une deuxième bourse d’une valeur de 1 M$ US assortie d’un soutien [...]
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update
08/05/2026
- Data from Phase 1b/2 trial of evorpacept + zanidatamab presented at ESMO Breast Cancer 2026 showed all patients with confirmed HER2-positive disease and high CD47 expression experienced durable responses to this [...]

Pages